Table 2.

Multiple Regression Modeling in Adult Patients With Adrenal Insufficiency (147 complete clinical assessments from 117 patients)

Model 1 (P < 0.001*)Dependent: PRC
IndependentB95% CI lower bound95% CI upper boundP
MC total daily dose0.001–0.0010.0020.515
K  +0.044–0.2010.2890.723
Na  +–0.091–0.126–0.055<0.001*
MAP0.005–0.0060.0160.351
Age–0.006–0.0130.0010.072
BMI0.004–0.0120.0200.591
Model 2 (P = 0.017*)Dependent: MC total daily dose
IndependentB95% CI lower bound95% CI upper boundP
K  +–17.523–43.3508.3030.182
Na  +1.026–3.0725.1230.621
PRC5.846–11.87323.5650.515
MAP0.566–0.5931.7260.336
Age0.030–0.7220.7810.938
BMI2.8121.1834.4410.001*
Model 1 (P < 0.001*)Dependent: PRC
IndependentB95% CI lower bound95% CI upper boundP
MC total daily dose0.001–0.0010.0020.515
K  +0.044–0.2010.2890.723
Na  +–0.091–0.126–0.055<0.001*
MAP0.005–0.0060.0160.351
Age–0.006–0.0130.0010.072
BMI0.004–0.0120.0200.591
Model 2 (P = 0.017*)Dependent: MC total daily dose
IndependentB95% CI lower bound95% CI upper boundP
K  +–17.523–43.3508.3030.182
Na  +1.026–3.0725.1230.621
PRC5.846–11.87323.5650.515
MAP0.566–0.5931.7260.336
Age0.030–0.7220.7810.938
BMI2.8121.1834.4410.001*

The dependent variables assessed were plasma renin concentration, sodium, potassium, mineralocorticoid dose, and mean arterial pressure. P values should be interpreted with Bonferroni correction; when significant, they are highlighted in bold and marked with an asterisk. Abbreviations: BMI, body mass index; K+, serum potassium; MAP, mean arterial blood pressure; Na+, serum sodium; PRC, plasma renin concentration.

Table 2.

Multiple Regression Modeling in Adult Patients With Adrenal Insufficiency (147 complete clinical assessments from 117 patients)

Model 1 (P < 0.001*)Dependent: PRC
IndependentB95% CI lower bound95% CI upper boundP
MC total daily dose0.001–0.0010.0020.515
K  +0.044–0.2010.2890.723
Na  +–0.091–0.126–0.055<0.001*
MAP0.005–0.0060.0160.351
Age–0.006–0.0130.0010.072
BMI0.004–0.0120.0200.591
Model 2 (P = 0.017*)Dependent: MC total daily dose
IndependentB95% CI lower bound95% CI upper boundP
K  +–17.523–43.3508.3030.182
Na  +1.026–3.0725.1230.621
PRC5.846–11.87323.5650.515
MAP0.566–0.5931.7260.336
Age0.030–0.7220.7810.938
BMI2.8121.1834.4410.001*
Model 1 (P < 0.001*)Dependent: PRC
IndependentB95% CI lower bound95% CI upper boundP
MC total daily dose0.001–0.0010.0020.515
K  +0.044–0.2010.2890.723
Na  +–0.091–0.126–0.055<0.001*
MAP0.005–0.0060.0160.351
Age–0.006–0.0130.0010.072
BMI0.004–0.0120.0200.591
Model 2 (P = 0.017*)Dependent: MC total daily dose
IndependentB95% CI lower bound95% CI upper boundP
K  +–17.523–43.3508.3030.182
Na  +1.026–3.0725.1230.621
PRC5.846–11.87323.5650.515
MAP0.566–0.5931.7260.336
Age0.030–0.7220.7810.938
BMI2.8121.1834.4410.001*

The dependent variables assessed were plasma renin concentration, sodium, potassium, mineralocorticoid dose, and mean arterial pressure. P values should be interpreted with Bonferroni correction; when significant, they are highlighted in bold and marked with an asterisk. Abbreviations: BMI, body mass index; K+, serum potassium; MAP, mean arterial blood pressure; Na+, serum sodium; PRC, plasma renin concentration.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close